Osteopontin in Cardiovascular Diseases

Area of Science:

• Cardiovascular Medicine
• Biochemistry
• Molecular Biology

Background:

• Cardiovascular diseases (CVDs) remain a leading global cause of mortality despite significant progress in secondary prevention.
• Residual risk factors, including inflammation and pro-thrombotic states, necessitate novel therapeutic strategies.
• Osteopontin (OPN), a matricellular protein, plays a complex role in various cardiovascular pathologies.

Purpose of the Study:

• To review the multifaceted role of Osteopontin (OPN) in the pathogenesis of cardiovascular diseases (CVDs).
• To explore the potential of OPN as a novel therapeutic target for managing CVDs.
• To discuss the dualistic nature of OPN's function in different cardiovascular pathological states.

Main Methods:

• Literature review of studies investigating Osteopontin (OPN) in cardiovascular disease.
• Analysis of clinical trial data, including the Canakinumab Anti-inflammatory Thrombosis Outcomes Study.
• Synthesis of evidence on OPN's biological functions and clinical implications in CVDs.

Main Results:

• Acute elevation of OPN demonstrates protective effects, aiding wound healing, neovascularization, and reducing vascular calcification.
• Chronic elevation of OPN is associated with poor prognosis for major adverse cardiovascular events, independent of traditional risk factors.
• The dual role of OPN suggests context-dependent therapeutic potential.

Conclusions:

• Osteopontin (OPN) presents a complex, dual role in cardiovascular disease development and progression.
• Targeting OPN may offer a novel therapeutic avenue for cardiovascular diseases, although clinical availability is currently limited.
• Further research is warranted to elucidate OPN's precise mechanisms and optimize its therapeutic application in CVDs.